Építés alatt – nem éles oldal
Belépés
LeállítvaNo phase

Antiretroviral Improvement Among Medicaid Enrollees

Megadott ok: Insufficient rate of accrual

Key facts

Where
Richmond, Egyesült ÁllamokSee the site

Where in Egyesült Államok

  • Virginia Commonwealth UniversityRichmond, Egyesült ÁllamokNo longer taking part

Trial details

Who runs it
Virginia Commonwealth University
Trial code
NCT05477485
Record updated
2025. október 21.
Original description
This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.Read full original descriptionShow less

Antiretroviral Improvement Among Medicaid Enrollees (AIMS): An Insurance-based Data to Care Initiative for Medicaid Enrollees in Virginia

This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.

Inclusion: Current enrollment in Virginia Medicaid; Continuous Virginia Medicaid enrollment for the preceding 9 or more months; Current age 19-64 years; Identified as living with HIV according to an HIV case identification algorithm; Non-dual eligible for Medicare; History of ART prescription claim(s) within the past 12 months; Prior ART prescription claim, with claims for the most recent ART prescription refill(s) >30 days late.

Exclusion: New prescription claim(s) within 30 days for within-class ART drug(s) not previously prescribed; Service claim(s) for resistance testing and other ART prescription claim(s) within 30 days of most recent late ART prescription(s) for ART drug(s) not previously prescribed; Enrollee's linked HIV provider practices at a healthcare facility offering PositiveLinks; No record in the Virginia HIV surveillance data; Record of non-Medicaid health insurance or other health care service payer in past 3 months; Non-English speaking.

ClinicalTrials.gov NCT05477485